LifeStance Health (LFST) Gains from Investment Securities (2021 - 2026)

LifeStance Health (LFST) has 6 years of Gains from Investment Securities data on file, last reported at $5.5 million in Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $5.5 million, down 54.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.5 million (down 54.01% YoY), and the FY2025 annual result was $13.5 million, down 1.43% from the prior year.
• Gains from Investment Securities retreated to $5.5 million in Q1 2026 per LFST's latest filing, from $10.1 million in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $13.5 million in Q3 2024 and troughed at -$1.4 million in Q4 2024.
• A 5-year average of $4.4 million and a median of $17755.0 in 2023 frame the typical range for Gains from Investment Securities.
• On a YoY basis, Gains from Investment Securities climbed as much as 99900.0% in 2024 and fell as far as 243.99% in 2024.
• A 5-year view of Gains from Investment Securities shows it stood at -$482000.0 in 2022, then rose by 13.69% to -$416000.0 in 2023, then sank by 243.99% to -$1.4 million in 2024, then surged by 808.94% to $10.1 million in 2025, then tumbled by 45.76% to $5.5 million in 2026.
• Business Quant data shows LFST's Gains from Investment Securities at $5.5 million in Q1 2026, $10.1 million in Q4 2025, and $13.5 million in Q3 2025.